Clinician–Scientist Training in Addiction Medicine: A Novel Program in a Canadian Setting

To the Editor: Medical education has long been the missing element in the response to the global addiction problem. Instead of treating addiction as a disease, governments have focused on drug prohibition and law enforcement. This approach has failed by many measures, and, as a result, millions of people have suffered. Addiction science has increasingly identified a range of evidence-based approaches to treat substance use disorders, particularly through early identification and treatment. However, most interventions are underused. Better physician education can improve accurate use of evidence-based treatments. The demand for training outstretches our capacity by 30% to 40% and poses a serious challenge to our vision of training the next generation of addiction doctors. To address this unmet demand, training in addiction medicine should be standardized and scaled up.1 The key components of such a training program should include clinical experiences in detoxification protocols, inpatient consultation, youth addiction and mental health, residential treatment focused on women, chronic pain management, and longitudinal community-based treatment. Ideally, all health care providers involved in care of people with substance use disorders should take it, including those in primary care or internal medicine, social work, and nursing. To this end, a promising initiative has recently been launched at the University of British Columbia and St. Paul’s Hospital—that is, a large addiction medicine fellowship. The fellowship provides 12 months of specialized training for physicians from general practice, internal medicine, and psychiatry. The Addiction Medicine Foundation (AMF) accredited the fellowship, and alumni are encouraged to write AMF exams. In addition, they obtain research training through intensive mentorship and quality opportunities to develop and publish research manuscripts through academic half-days, journal clubs, and conferences. They receive media training, learn to influence public policy, advocate for patients, and lead academic research projects. Most health systems do not specifically train generalist doctors in addiction medicine; when they do, this is mostly privileged to a handful of psychiatry programs that train a definite number of addiction psychiatrists. Our fellowship trains family physicians, internists, and individuals from other disciplines and thus expands the specialist treatment workforce to professionals frequently seeing people with substance use disorders who are well positioned to bridge the implementation gap.2 Access to effective treatments grows. Jan Klimas, MSc, PhDPostdoctoral fellow, British Columbia Centre on Substance Use, Department of Medicine, University of British Columbia, St. Paul’s Hospital, Vancouver, British Columbia, Canada, and postdoctoral fellow, School of Medicine, University College Dublin, Dublin, Ireland; [email protected]; ORCID: http://orcid.org/0000-0002-5179-0052. Ryan McNeil, PhDResearch scientist, British Columbia Centre on Substance Use, and assistant professor, Department of Medicine, University of British Columbia, St. Paul’s Hospital, Vancouver, British Columbia; ORCID: http://orcid.org/0000-0001-9555-7693. Will Small, PhDResearch scientist, British Columbia Centre on Substance Use, Department of Medicine, University of British Columbia, St. Paul’s Hospital, and interim director, Centre for Applied Research in Mental Health and Addiction (CARMHA), and assistant professor, Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada. Walter Cullen, MDProfessor of urban general practice, School of Medicine, University College Dublin, Health Sciences Centre, Belfield, Dublin, Ireland; ORCID: http://orcid.org/0000-0003-1838-5052.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.